20 Results for "

bacterial dihydrofolate reductase

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "bacterial dihydrofolate reductase" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-B0512
CAS No.: 127-79-7
Synonyms: RP2632
Sulfamerazine (RP2632) is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine can be used for the research of Parkinson’s disease and bacterial infection .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101479
CAS No.: 192314-93-5
Purity:  99.49%
Synonyms: AR-100
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL.
loading...
    loading...
Cat. No.: HY-19581
CAS No.: 102280-35-3
Baquiloprim is an orally active Antibiotic and selective inhibitor of Bacterial Dihydrofolate reductase (DHFR), with an IC50 of 19 nM against E. coli and an IC50 of 190 μM against rat liver dihydrofolate reductase. Baquiloprim is a bacteriostatic broad-spectrum antibacterial agent that acts against Gram-negative and Gram-positive bacteria. Baquiloprim inhibits glucuronidation in cultured hepatocytes. Baquiloprim can be used in research related to Pasteurella haemolytica infection, bacterial infection, Escherichia coli diarrhea, bacterial infection in pigs, and pneumonic pasteurellosis .
loading...
    loading...
Cat. No.: HY-B0512A
CAS No.: 127-58-2
Synonyms: RP2632 sodium
Sulfamerazine (RP2632) sodium is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine sodium inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine sodium inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine sodium can be used for the research of Parkinson’s disease and bacterial infection .
loading...
    loading...
Cat. No.: HY-122289
CAS No.: 68902-57-8
Research Areas:  

Infection

Metioprim is a competitive inhibitor of bacterial Dihydrofolate reductase (DHFR). Metioprim has inhibitory activity against anaerobic bacteria. Metioprim shows synergistic activity in combination with DDS (HY-B0688) against E. coli. and various mycobacteria .
loading...
    loading...
Cat. No.: HY-139743
CAS No.: 56066-63-8
Purity:  99.68%
Synonyms: Aditoprim
Target:  

Antifolate Bacterial

Research Areas:  

Infection

Aditoprime (Aditoprim) is a selective bacterial dihydrofolate reductase (DHFR) inhibitor with IC50s of 47 and 520 nM for E.coli and L.casei DHFR, respectively. Aditoprime inhibits the transformation of dihydrofolic acid to tetrahydrofolic acid. Aditoprime has a broad-spectrum antibacterial activity and excellent pharmacokinetics .
loading...
    loading...
Cat. No.: HY-19581S
CAS No.: 1228182-50-0
Baquiloprim-d6 is the deuterated-labeled Baquiloprim (HY-19581). Baquiloprim is an orally active Antibiotic and selective inhibitor of Bacterial Dihydrofolate reductase (DHFR), with an IC50 of 19 nM against E. coli and an IC50 of 190 μM against rat liver dihydrofolate reductase. Baquiloprim is a bacteriostatic broad-spectrum antibacterial agent that acts against Gram-negative and Gram-positive bacteria. Baquiloprim inhibits glucuronidation in cultured hepatocytes. Baquiloprim can be used in research related to Pasteurella haemolytica infection, bacterial infection, Escherichia coli diarrhea, bacterial infection in pigs, and pneumonic pasteurellosis .
loading...
    loading...
Cat. No.: HY-19581R
CAS No.: 102280-35-3
Baquiloprim (Standard) is the analytical standard of Baquiloprim (HY-19581). This product is intended for research and analytical applications. Baquiloprim is an orally active Antibiotic and selective inhibitor of Bacterial Dihydrofolate reductase (DHFR), with an IC50 of 19 nM against E. coli and an IC50 of 190 μM against rat liver dihydrofolate reductase. Baquiloprim is a bacteriostatic broad-spectrum antibacterial agent that acts against Gram-negative and Gram-positive bacteria. Baquiloprim inhibits glucuronidation in cultured hepatocytes. Baquiloprim can be used in research related to Pasteurella haemolytica infection, bacterial infection, Escherichia coli diarrhea, bacterial infection in pigs, and pneumonic pasteurellosis .
loading...
    loading...
Cat. No.: HY-161292
Research Areas:  

Infection

DHFR-IN-16 (compound 8d) is an inhibitor of dihydrofolate reductase (DHFR) (IC50=0.199 μM) and can be used in anti-infectious research .
loading...
    loading...
Cat. No.: HY-176247
CAS No.: 2995300-60-0
Target:  

Bacterial

Research Areas:  

Infection

DHFS-IN-1 (Compound 3) is a dihydrofolate synthetase (DHFS) inhibitor with an IC50 value of 2.6 μM. DHFS-IN-1 can be used in research on infectious diseases related to bacterial folate synthesis .
loading...
    loading...
Cat. No.: HY-101479R
CAS No.: 192314-93-5
Synonyms: AR-100 (Standard)
Research Areas:  

Infection

Iclaprim (Standard) is the analytical standard of Iclaprim. This product is intended for research and analytical applications. Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL.
loading...
    loading...
Cat. No.: HY-101479S
CAS No.: 1130072-57-9
Iclaprim-d6 (AR-100-d6) is the deuterium labeled Iclaprim. Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 μg/mL.
loading...
    loading...
Cat. No.: HY-139743R
CAS No.: 56066-63-8
Synonyms: Aditoprim (Standard)
Research Areas:  

Infection

Aditoprime (Standard) is a selective bacterial dihydrofolate reductase (DHFR) inhibitor with IC50s of 47 and 520 nM for E.coli and L.casei DHFR, respectively. Aditoprime inhibits the transformation of dihydrofolic acid to tetrahydrofolic acid. Aditoprime has a broad-spectrum antibacterial activity and excellent pharmacokinetics .
loading...
    loading...
Cat. No.: HY-177337
CAS No.: 56066-19-4
Synonyms: N-Didesmethyl-ADP
Research Areas:  

Infection

N-Didesmethyladitoprim is a metabolite of Aditoprime (HY-139743). Aditoprime is a selective bacterial dihydrofolate reductase (DHFR) inhibitor with IC50s of 47 and 520 nM for E.coli and L.casei DHFR , respectively. Aditoprime inhibits the transformation of dihydrofolic acid to tetrahydrofolic acid. Aditoprime has a broad-spectrum antibacterial activity and excellent pharmacokinetics .
loading...
    loading...
Cat. No.: HY-B0512R
CAS No.: 127-79-7
Synonyms: RP2632 (Standard)
Sulfamerazine (Standard) is the analytical standard of Sulfamerazine. This product is intended for research and analytical applications. Sulfamerazine (RP2632) is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine can be used for the research of Parkinson’s disease and bacterial infection .
loading...
    loading...
Cat. No.: HY-B0512S
CAS No.: 1020719-84-9
Synonyms: RP2632-d4
Sulfamerazine-d4 is a deuterium labeled Sulfamerazine. Sulfamerazine (RP2632) is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine can be used for the research of Parkinson’s disease and bacterial infection .
loading...
    loading...
Cat. No.: HY-B0512S1
CAS No.: 1196157-80-8
Synonyms: RP2632-13C6
Sulfamerazine- 13C6 (RP2632- 13C6) is 13C labeled Sulfamerazine (HY-B0512). Sulfamerazine (RP2632) is a brain-penetrant and orally active sulfonamide antibiotic and α-synuclein inhibitor with human α-synuclein KD of 352 μM. Sulfamerazine inhibits the synthesis of dihydrofolate by bacteria, thereby inhibiting bacterial growth. Sulfamerazine inhibits α-synuclein fibrillation, reduces α-synuclein aggregation-associated toxicity and α-synuclein aggregate accumulation. Sulfamerazine can be used for the research of Parkinson’s disease and bacterial infection .
loading...
    loading...
Cat. No.: HY-181100
Research Areas:  

Infection

DHFR-IN-26 is an Escherichia coli dihydrofolate reductase (ecDHFR) inhibitor with an IC50 of 0.75 nM. DHFR-IN-26 exerts broad-spectrum antibacterial activity. DHFR-IN-26 disrupts folate metabolism, nucleotide synthesis, and bacterial amino acid metabolic pathways. DHFR-IN-26 disrupts bacterial inner membranes, inhibited biofilm formation, and attenuated phage-related processes. DHFR-IN-26 shows lower toxicity to non-cancerous cells. DHFR-IN-26 can be used for the research of bacterial infections (including infections caused by methicillin-resistant Staphylococcus aureus, multidrug-resistant Escherichia coli, multidrug-resistant Pseudomonas aeruginosa, and lysogenic bacteria) .
loading...
    loading...
Cat. No.: HY-184851
CAS No.: 1347860-96-1
Synonyms: Dihydrotriazine
Target:  

Drug Derivative

Research Areas:  

Infection

1,2-Dihydro-1,2,3-triazine (Dihydrotriazine) is a sister compound of WR99210 (HY-116387). WR99210 is a dihydrofolate reductase inhibitor that exhibits in vitro activity against Nocardia species .
loading...
    loading...
Cat. No.: HY-187213
Research Areas:  

Infection

Anti-MRSA agent 45 is a dihydrofolate reductase (DHFR) inhibitor and membrane-disrupting agent. Anti-MRSA agent 45 disrupts MRSA membrane integrity, increases membrane permeability and induces bacterial morphological damage. Anti-MRSA agent 45 exerts rapid, time- and concentration-dependent bactericidal activity against MRSA, and inhibits MRSA biofilm formation. Anti-MRSA agent 45 is applicable to research related to MRSA infection .
loading...
    loading...
  • 1